
Ian D. Dang
Examiner (ID: 17375)
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647 |
| Total Applications | 358 |
| Issued Applications | 151 |
| Pending Applications | 21 |
| Abandoned Applications | 186 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 296163
[patent_doc_number] => 07541434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants'
[patent_app_type] => utility
[patent_app_number] => 11/726234
[patent_app_country] => US
[patent_app_date] => 2007-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 146952
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541434.pdf
[firstpage_image] =>[orig_patent_app_number] => 11726234
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/726234 | Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants | Mar 20, 2007 | Issued |
Array
(
[id] => 7811336
[patent_doc_number] => 08133867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Method for treating rheumatoid arthritis with an antibody that binds to a hepatocyte growth factor receptor'
[patent_app_type] => utility
[patent_app_number] => 12/293541
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3741
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133867.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293541
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293541 | Method for treating rheumatoid arthritis with an antibody that binds to a hepatocyte growth factor receptor | Mar 19, 2007 | Issued |
Array
(
[id] => 5473030
[patent_doc_number] => 20090246196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'COMBINED TARGETED THERAPY FOR THE TREATMENT OF PROLIFERATIVE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/282618
[patent_app_country] => US
[patent_app_date] => 2007-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4572
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246196.pdf
[firstpage_image] =>[orig_patent_app_number] => 12282618
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/282618 | COMBINED TARGETED THERAPY FOR THE TREATMENT OF PROLIFERATIVE DISEASE | Mar 14, 2007 | Abandoned |
Array
(
[id] => 4652147
[patent_doc_number] => 20080039403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/678784
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5967
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039403.pdf
[firstpage_image] =>[orig_patent_app_number] => 11678784
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/678784 | Alpha-fetoprotein peptides and uses thereof | Feb 25, 2007 | Issued |
Array
(
[id] => 5398283
[patent_doc_number] => 20090318346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'BIVALENT ErbB LIGAND BINDING MOLECULES AND METHODS FOR THEIR PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 12/278751
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7903
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318346.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278751 | BIVALENT ErbB LIGAND BINDING MOLECULES AND METHODS FOR THEIR PREPARATION AND USE | Feb 7, 2007 | Abandoned |
Array
(
[id] => 5271518
[patent_doc_number] => 20090075294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Eukaryotic mechanosensory transduction channel'
[patent_app_type] => utility
[patent_app_number] => 11/703343
[patent_app_country] => US
[patent_app_date] => 2007-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22853
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075294.pdf
[firstpage_image] =>[orig_patent_app_number] => 11703343
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/703343 | In vitro method for identifying a compound using an eukaryotic mechanosensory transduction channel | Feb 5, 2007 | Issued |
Array
(
[id] => 5079160
[patent_doc_number] => 20070122384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Method for treating inflammatory bowel disease'
[patent_app_type] => utility
[patent_app_number] => 11/641163
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2310
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122384.pdf
[firstpage_image] =>[orig_patent_app_number] => 11641163
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/641163 | Method for treating inflammatory bowel disease | Dec 18, 2006 | Abandoned |
Array
(
[id] => 5219267
[patent_doc_number] => 20070160578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Expansion of natural killer and CD8 T-cells with IL-15R/ligand activator complexes'
[patent_app_type] => utility
[patent_app_number] => 11/639877
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18174
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11639877
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/639877 | Expansion of natural killer and CD8 T-cells with IL-15R/ligand activator complexes | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5199119
[patent_doc_number] => 20070298437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A CHLORIDE INTRACELLULAR CHANNEL 1 PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 11/608747
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31514
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11608747
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/608747 | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein | Dec 7, 2006 | Issued |
Array
(
[id] => 7967059
[patent_doc_number] => 07939637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Insulin-like growth factor antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/608705
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30108
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939637.pdf
[firstpage_image] =>[orig_patent_app_number] => 11608705
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/608705 | Insulin-like growth factor antibodies and uses thereof | Dec 7, 2006 | Issued |
Array
(
[id] => 4797856
[patent_doc_number] => 20080009442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'THERAPEUTIC USE FOR ALPHA1 PROTEINASE INHIBITOR IN HEMATOPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 11/566903
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17179
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009442.pdf
[firstpage_image] =>[orig_patent_app_number] => 11566903
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/566903 | THERAPEUTIC USE FOR ALPHA1 PROTEINASE INHIBITOR IN HEMATOPOIESIS | Dec 4, 2006 | Abandoned |
Array
(
[id] => 8784687
[patent_doc_number] => 08431531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same'
[patent_app_type] => utility
[patent_app_number] => 12/095346
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5421
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12095346
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095346 | Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same | Nov 29, 2006 | Issued |
Array
(
[id] => 9009568
[patent_doc_number] => 08524866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the same'
[patent_app_type] => utility
[patent_app_number] => 12/224648
[patent_app_country] => US
[patent_app_date] => 2006-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 10965
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12224648
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224648 | Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the same | Nov 14, 2006 | Issued |
Array
(
[id] => 5096143
[patent_doc_number] => 20070117752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Glucagon-like-peptide-2 (GLP-2) analogues'
[patent_app_type] => utility
[patent_app_number] => 11/595496
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29535
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595496 | Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analogues | Nov 8, 2006 | Issued |
Array
(
[id] => 5148167
[patent_doc_number] => 20070048223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/553835
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85800
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048223.pdf
[firstpage_image] =>[orig_patent_app_number] => 11553835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/553835 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 26, 2006 | Abandoned |
Array
(
[id] => 5148166
[patent_doc_number] => 20070048222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/553821
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85806
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048222.pdf
[firstpage_image] =>[orig_patent_app_number] => 11553821
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/553821 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 26, 2006 | Abandoned |
Array
(
[id] => 5119250
[patent_doc_number] => 20070140964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/553241
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85758
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20070140964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11553241
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/553241 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 25, 2006 | Abandoned |
Array
(
[id] => 5119249
[patent_doc_number] => 20070140963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/553219
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85793
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20070140963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11553219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/553219 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 25, 2006 | Abandoned |
Array
(
[id] => 5148773
[patent_doc_number] => 20070048833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/552688
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85806
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048833.pdf
[firstpage_image] =>[orig_patent_app_number] => 11552688
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/552688 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 24, 2006 | Abandoned |
Array
(
[id] => 5148774
[patent_doc_number] => 20070048834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/552710
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85820
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048834.pdf
[firstpage_image] =>[orig_patent_app_number] => 11552710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/552710 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 24, 2006 | Abandoned |